Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015

References

• Gordon PH. Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. A&D. 2013;04:295–310.
   Google Scholar
• Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta‐analysis. J Neurol Neurosurg Psychiatry. 2011;82:623–7.
   PubMed Web of Science ®Google Scholar
• Beghi E, Logroscino G, Chiò A, Hardiman O, Millul A, Mitchell D, et al. Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population‐based pilot case‐control study. Amyotrophic Lateral Scler. 2010;11:289–92.
   PubMed Web of Science ®Google Scholar
• Fallis BA, Hardiman O. Aggregation of neurodegenerative disease in ALS kindreds. Amyotrophic Lateral Scler. 2009;10:95–8.
   PubMed Web of Science ®Google Scholar
• Das K, Nag C, Ghosh M. Familial, environmental, and occupational risk factors in development of amyotrophic lateral sclerosis. North Am J Med Sci. 2012;4:350–5.
   PubMedGoogle Scholar
• Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the ‘common’ neurologic disorders?. Neurology. 2007;68:326–37.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118–30.
   PubMed Web of Science ®Google Scholar
• Doi Y, Atsuta N, Sobue G, Morita M, Nakano I. Prevalence and incidence of amyotrophic lateral sclerosis in Japan. J Epidemiol. 2014;24:494–9.
   PubMed Web of Science ®Google Scholar
• Mehta P, Kaye W, Raymond J, Punjani R, Larson T, Cohen J, et al. Prevalence of amyotrophic lateral sclerosis — United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67:1285–9.
   PubMed Web of Science ®Google Scholar
• Marin B, Boumédiene F, Logroscino G, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
   PubMed Web of Science ®Google Scholar
• Wagner L, Archer NP, Williamson DM, Henry JP, Schiffer R, Jackson CE, et al. Prevalence of amyotrophic lateral sclerosis in Texas, 1998–2003. Texas Med. 2012;108:e1.
   PubMedGoogle Scholar
• Nelson LM, van den Eeden SK, Tanner CM, Bernstein AL. Incidence of amyotrophic lateral sclerosis in a multiethnic health care organization. Neuroepidemiology. 2010;34:276.
   Google Scholar
• Pupillo E, Messina P, Logroscino G, Beghi E. Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol. 2014;75:287–97.
   PubMed Web of Science ®Google Scholar
• Jordan H, Fagliano J, Rechtman L, Lefkowitz D, Kaye W. Effects of demographic factors on survival time after a diagnosis of amyotrophic lateral sclerosis. Neuroepidemiology. 2015;44:114–20.
   PubMed Web of Science ®Google Scholar
• Cetin H, Rath J, Fuzi J, Reichardt B, Fulop G, Koppi S, et al. Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course. Neuroepidemiology. 2015;44:6–15.
   PubMed Web of Science ®Google Scholar
• Paulukonis ST, Roberts EM, Valle JP, Collins NN, English PB, Kaye WE. Survival and cause of death among a cohort of confirmed amyotrophic lateral sclerosis cases. PLoS One. 2015;10:e0131965.
   PubMed Web of Science ®Google Scholar
• Antao VC, Horton DK. The National Amyotrophic Lateral Sclerosis (ALS) Registry. J Environ Health. 2012;75:28–30.
   PubMed Web of Science ®Google Scholar
• Kaye WE, Sanchez M, Wu J. Feasibility of creating a National ALS Registry using administrative data in the United States. Amyotrophic Lateral Scler Frontotemporal Degener. 2014;15:433–9.
   PubMed Web of Science ®Google Scholar
• Wagner L, Rechtman L, Jordan H, Ritsick M, Sanchez M, Sorenson E, et al. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotrophic Lateral Scler Frontotemporal Degener. 2015;23:1–7.
   Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: Revised criteria for the diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disorder. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Microsoft Excel [computer program]. Redmond, Washington: Microsoft; 2016
   Google Scholar
• SAS Institute Inc. [computer program]. Base SAS® 9.3 Procedures Guide. Cary, NC: SAS Institute Inc; 2011.
   Google Scholar
• US Census Bureau. Race and Hispanic or Latino Origin 2010, 2010 Census Summary. Washington, DC: US Department of Commerce, US Census Bureau; 2010. Available at: https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=CF
   Google Scholar
• Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, et al. Prevalence of Amyotrophic Lateral Sclerosis – United States, 2010-2011. MMWR Surveill Summ. 2014;63:1–14.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Ragonese P, Cellura E, Aridon P, D’amelio M, Spataro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population-based study. Amyotrophic Lateral Scler. 2012;13:284–7.
   PubMed Web of Science ®Google Scholar
• Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68:1002–7.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study. Lancet Neurol. 2018;17:1083–97.
   PubMed Web of Science ®Google Scholar
• Marin B, Logroscino G, Boumédiene F, Labrunie A, Couratier P, Babron M-C, et al. Clinical and demographic factors and outcomes of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31:229.
   PubMed Web of Science ®Google Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population. Neurology. 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Freer C, Hylton T, Jordan HM, Kaye WE, Singh S, Huang Y, et al. Results of Florida’s Amyotrophic Lateral Sclerosis Surveillance Project, 2009–2011. BMJ Open. 2015;5:e007359.
   PubMed Web of Science ®Google Scholar
• Valle J, Roberts E, Collins N, Paulukonis S, English P, Kaye W. Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California. Amyotrophic Lateral Scler Frontotemporal Degener. 2015;16:209–15.
   Google Scholar
• Traynor BJ, Alexander M, Corr B, et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population-based study, 1996–2000. J Neurol Neurosurg Psychiatry. 2003;74:1258–61.
   PubMed Web of Science ®Google Scholar
• Martin S, Trevor-Jones E, Khan S, Shaw K, Marchment D, Kulka A, et al. The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison. Amyotrophic Later Scler Fr. 2017;18:569–75.
   PubMed Web of Science ®Google Scholar